NCT03135912View on ClinicalTrials.gov

Three-Arm Trial of Novel Treatment for Tinea Pedis

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 3, 2017

Primary Completion Date

August 2, 2017

Study Completion Date

August 2, 2017

Conditions
Tinea Pedis
Interventions
DRUG

Experimental Drug SESC 01

Topical experimental treatment comprising a combination of approved topical therapies and a new dosage method.

DRUG

Placebo

Dosage method of SESC 01, without active ingredients.

DRUG

Terbinafine Hydrochloride

Topical terbinafine hydrochloride cream.

Trial Locations (1)

01757

Kuchnir Dermatology & Dermatologic Surgery, Milford

All Listed Sponsors
lead

South End Skin Care

INDUSTRY

NCT03135912 - Three-Arm Trial of Novel Treatment for Tinea Pedis | Biotech Hunter | Biotech Hunter